Please login to the form below

Not currently logged in
Email:
Password:

UCB's Steve Arnold joins ABPI board

Will work to support life sciences in the UK

Steve Arnold joins UCB from GileadThe Association for the British Pharmaceutical Industry (ABPI has appointed UCB's Steve Arnold to its board of management.

Arnold joined UCB in May this year as managing director of the British and Irish Isles folliwng a spell in Canada working for Gilead Sciences.

He will serve as board member of the ABPPI – the UK's trade body for the pharma industry – up to 2014.

“As a leading UK pharma investor, UCB believes that harnessing this scientific innovation and increasing our R&D focus is key to improving the UK's future prosperity and as a member of the ABPI's board of management I will be working to ensure that life sciences remain vibrant in the UK,” said Arnold.

“This is particularly important at such a challenging time for our industry when we are looking for the Government to provide the right fiscal, R&D and commercial environment for our industry to thrive.”

31st July 2013

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics